BioWorld - Thursday, June 4, 2026

BioWorld Science

Jan. 28, 2019

View Archived Issues

lncRNA 00607 as a tumor suppressor in hepatocellular carcinoma

Read More

Intrabone gene therapy with autologous HSCs for transfusion-dependent beta-thalassemia: phase I/II

Read More

Collateral undamage: novel arterial growth mechanism underlies neonatal heart regeneration

Read More

Mannin Research and McMaster University enter glaucoma drug collaboration

Read More

NIAID initiates phase I study of the VRC-HIVRGP096-00-VP HIV vaccine

Read More

Myelin can regenerate in MS but mostly doesn't

Read More

Recombination, mutation probabilities linked

Read More

Immunosuppressive peptide R9-SOCS1-KIR prevents ocular damage in models of autoimmune uveitis

Read More

VCN-01 shows promising activity in preclinical models and in phase I study of retinoblastoma

Read More

Novo Nordisk initiates phase I pharmacokinetic study of NNC0148-0287sema in type 2 diabetes

Read More

New phase I trial investigates use of MK-5475 in moderate to severe PAH

Read More

SRPK1 found as therapeutic target for treating acute myeloid leukemia

Read More

I-Mab Biopharma begins first-in-human study of TJ-003234

Read More

Withyou Biotechnology describes new ACE inhibitors

Read More

Destiny Pharma reports data from second phase I safety study of XF-73

Read More

FDA approves Imbruvica with obinutuzumab for treatment-naive CLL/SLL

Read More

Vaccine targeting mucin-1 designed to function in immunotolerant hosts

Read More

Phase III study of Ultomiris in aHUS meets primary objective of complete TMA response

Read More

FDA lifts partial clinical hold on phase I studies of MGD-009

Read More